Sandoz Group AG (LON:0SAN)

London flag London · Delayed Price · Currency is GBP · Price in CHF
66.23
+0.80 (1.23%)
Mar 4, 2026, 5:14 PM GMT
Market Cap27.55B +62.5%
Revenue (ttm)8.29B +7.4%
Net Income679.10M
EPS1.55
Shares Outn/a
PE Ratio40.57
Forward PE20.96
Dividend0.55 (0.82%)
Ex-Dividend DateApr 17, 2025
Volume73,068
Average Volume239,822
Open65.92
Previous Close65.43
Day's Range65.62 - 66.72
52-Week Range26.99 - 72.69
Beta0.26
RSI52.45
Earnings DateFeb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1886
Employees 20,000
Stock Exchange London Stock Exchange
Ticker Symbol 0SAN
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements